Study Finds Stem Cell Transplant Keeps MS Quiet in Most Patients for Two Years
A new real-world study suggests autologous stem cell transplant can keep multiple sclerosis quiet for at least two years in most patients, with the strongest benefits seen in people with relapsing-remitting MS and highly active disease. The findings add fresh momentum to a treatment strategy that aims to reset the immune system rather than simply suppress it.